David Young
Pres. Research & Development, Director at Processa Pharmaceuticals, Inc. (PCSA)
David Young has filed 37 insider reports with the SEC since June 2021, as pres. Research & Development and director at Processa Pharmaceuticals, Inc. (PCSA). In the last 12 months David Young bought $32.4K of stock on the open market. In the latest filing, on July 1, 2026, David Young bought 2,531 shares of Processa Pharmaceuticals, Inc. (PCSA) for $4,885 at an average of $1.93.
- Filings
- 37
- Companies
- 1
- Bought on market
- $382K
- Sold on market
- None
Companies where David Young is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Pres. Research & Development, Director | 21,729 | $382K | $1.24 | $1.69+36% | Jul 1, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 30, 2026+$4,885PCSAPres. Research & Development Young David bought $4,885 worth of shares (2,531 units at $1.93), increasing direct ownership by 13% to 21,729 unitsForm 4Open-market purchase
- Jun 15, 2026+$4,589PCSAPres. Research & Development Young David bought $4,589 worth of shares (2,067 units at $2.22), increasing direct ownership by 12% to 19,198 unitsForm 4Open-market purchase
- May 29, 2026+$4,590PCSAPres. Research & Development Young David bought $4,590 worth of shares (1,786 units at $2.57), increasing direct ownership by 12% to 17,131 unitsForm 4Open-market purchase
- May 15, 2026+$4,589PCSAPres. Research & Development Young David bought $4,589 worth of shares (1,545 units at $2.97), increasing direct ownership by 11% to 15,345 unitsForm 4Open-market purchase
- Apr 30, 2026+$4,589PCSAPres. Research & Development Young David bought $4,589 worth of shares (1,706 units at $2.69), increasing direct ownership by 14% to 13,813 unitsForm 4Open-market purchase
- Apr 15, 2026+$4,589PCSASEC Form 4 filed by Young DavidForm 4Open-market purchase
- Mar 31, 2026+$4,588PCSASEC Form 4 filed by Young DavidForm 4Open-market purchase
- Jan 1, 2026PCSAPres. Research & Development Young David converted options into 49 shares, increasing direct ownership by 0.56% to 8,752 unitsForm 4Exercise or conversion of a derivative
- Oct 1, 2025PCSASEC Form 4 filed by Pres. Research & Development Young DavidForm 4Grant or award
- Sep 18, 2025PCSAAmendment: SEC Form 4 filed by Pres. Research & Development Young DavidForm 4
- Jul 24, 2025PCSASEC Form 4 filed by Pres. Research & Development Young DavidForm 4Grant or award
- Apr 1, 2025PCSAPres. Research & Development Young David converted options into 17,272 shares and covered exercise/tax liability with 5,345 shares, increasing direct ownership by 6% to 217,332 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 29, 2025PCSAAmendment: SEC Form 4 filed by Pres. Research & Development Young DavidForm 4Grant or award
- Jan 27, 2025+$99.3KPCSAPres. Research & Development Young David bought $99,289 worth of shares (124,500 units at $0.80), increasing direct ownership by 154% to 205,405 unitsForm 4Open-market purchase
- Jul 10, 2024PCSAPres. Research & Development Young David converted options into 2,319 shares and covered exercise/tax liability with 800 shares, increasing direct ownership by 2% to 80,905 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 1, 2024PCSAYoung David converted options into 1,675 shares and covered exercise/tax liability with 518 shares, increasing direct ownership by 1% to 80,544 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 7, 2024+$51.5KPCSAYoung David bought $51,526 worth of shares (21,000 units at $2.45), increasing direct ownership by 36% to 79,387 unitsForm 4Open-market purchase
- Feb 6, 2024+$50.5KPCSAYoung David bought $50,504 worth of shares (20,000 units at $2.53)Form 4Open-market purchase
- Oct 12, 2023PCSAYoung David was granted 155,277 shares, increasing direct ownership by 25% to 767,701 unitsForm 4Grant or award
- Oct 10, 2023PCSAYoung David was granted 142,000 shares, increasing direct ownership by 30% to 612,424 unitsForm 4Grant or award
- Jun 12, 2023+$32KPCSASEC Form 4 filed by Young DavidForm 4Open-market purchase
- Apr 14, 2023+$11KPCSASEC Form 4 filed by Young DavidForm 4Open-market purchase
- Apr 13, 2023+$29KPCSASEC Form 4 filed by Young DavidForm 4Open-market purchase
- Feb 9, 2023PCSASEC Form 4: Young David was granted 18,750 shares, increasing direct ownership by 6% to 350,424 unitsForm 4Grant or award
- Jan 1, 2023PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Sep 30, 2022PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Aug 16, 2022PCSASEC Form 4: Young David gifted 9,250 shares, decreasing direct ownership by 2% to 377,784 unitsForm 4Gift
- Jun 30, 2022PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Apr 1, 2022PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Mar 31, 2022PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Dec 31, 2021PCSASEC Form 4 filed by Young David (Amendment)Form 4Grant or award
- Sep 30, 2021PCSASEC Form 4 filed by Young David (Amendment)Form 4Grant or award
- Dec 31, 2021PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Sep 30, 2021PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Jul 8, 2021PCSASEC Form 4 filed by Young DavidForm 4Grant or award
- Jun 23, 2021+$76.7KPCSASEC Form 4: Young David bought $76,716 worth of Common Stock (10,000 units at $7.67), increasing direct ownership by 3% to 345,190 unitsForm 4Open-market purchase
- Jun 8, 2021PCSASEC Form 4 filed by Young DavidForm 4Grant or award
Compare David Young with
- David Young vs Gregory J. Flesher1 shared
- David Young vs George K Ng1 shared
- David Young vs Sheila Gujrathi1 shared
- David Young vs Justin W Yorke1 shared
- David Young vs Russell Skibsted1 shared
- David Young vs Geraldine Pannu1 shared
Other insiders at the same companies
- Gregory J. FlesherPCSA
- George K NgPCSA
- Sheila GujrathiPCSA
- Justin W YorkePCSA
- Russell SkibstedPCSA
- Geraldine PannuPCSA
- James R NealPCSA
- Patrick LinPCSA
- Wendy GuyPCSA
- Khoso BaluchPCSA
- Sian BigoraPCSA
Questions about David Young
- What is David Young's role at Processa Pharmaceuticals, Inc.?
- David Young reports to the SEC as pres. Research & Development and director at Processa Pharmaceuticals, Inc. (PCSA), according to the latest filing on July 1, 2026.
- How many shares does David Young own?
- After the latest filing that states it, David Young directly owned 21,729 shares of Processa Pharmaceuticals, Inc. (PCSA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David Young bought or sold stock recently?
- The most recent open-market purchase was on June 30, 2026: bought 2,531 shares of Processa Pharmaceuticals, Inc. (PCSA) for $4,885 at an average of $1.93.
- How do I get alerts when David Young files?
- Follow David Young on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David Young (SEC CIK 0001378166). Totals count each trade once, skipping amendments whose original is on file, from Jun 10, 2021 on. View on SEC EDGAR · Get this as JSON